MedPath

ARTHRO Distension Plus Intensive Mobilisation in Shoulder Capsulitis

Phase 3
Completed
Conditions
Shoulder Capsulitis
Interventions
Procedure: ARTHRO distension plus intensive mobilisation
Procedure: infiltration intra articular
Registration Number
NCT00724113
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The purpose of this study is to evaluate the effectiveness of ARTHRO distension plus intensive mobilisation in shoulder capsulitis.

Detailed Description

The aim of the study is to evaluate a treatment of shoulder capsulitis that associates ARTHRO distension and intensive mobilisation at 2, 6, 12, 26 and 52 weeks. It is a bicentric 87-month (inclusion: 74 months; follow up: 13 months) observer blind randomised clinical trial using 2 groups in parallel. The number of patients to be included is 66. The treatment that is evaluated associates ARTHRO distension followed by mobilisation of the shoulder 6 hours per day during 5 days, and then sessions of physiotherapy for 4 weeks. The control intervention is one intra-articular injection of corticosteroids and physiotherapy. The primary outcome is SPADI, namely pain and disability, at 2 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • age ≥ 18 years
  • shoulder capsulitis
  • duration of symptoms ≥ 3 months
  • health insurance
Read More
Exclusion Criteria
  • cognitive disorders
  • Hypo coagulation
  • biological inflammatory syndrome
  • uncontrolled diabetes
  • XYLOCAINE allergy
  • pregnancy
  • unable to understand and to speak french
  • previous surgery of shoulder
  • shoulder infiltration or distension in the previous month
  • local contraindication to shoulder infiltration
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2ARTHRO distension plus intensive mobilisationARTHRO distension plus intensive mobilisation
1infiltration intra articularinfiltration intra articular
Primary Outcome Measures
NameTimeMethod
Pain and disability using SPADI score at 2 weeksat 2 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rheumatology department of Lariboisiere hospital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath